慢性肺源性心脏病患者采用安体舒通托拉塞米治疗效果剖析.docVIP

慢性肺源性心脏病患者采用安体舒通托拉塞米治疗效果剖析 　　[摘要]目的 探?慢性肺源性心脏病患者采用安体舒通和托拉塞米治疗的临床效果。方法 选取2015年6月～2016年12月我院收治的72例慢性肺源性心脏病患者作为研究对象，按照随机数表法，将患者均分为对照组和观察组，每组患者36例。对照组患者采取强心剂及利尿剂等常规方法治疗，观察组患者在对照组的基础上采用安体舒通及托拉塞米进行治疗。比较两组患者的治疗效果以及心功能分级情况。结果 观察组患者的治疗总有效率（97.22%）明显高于对照组（83.33%），差异有统计学意义（P0.05）。对照组患者治疗后的Ⅱ级例数多于治疗前，Ⅳ级例数少于治疗前，差异有统计学意义（P0.05）。观察组患者治疗后的两组患者的Ⅱ级例数多于治疗前，Ⅲ、Ⅳ级例数少于治疗前，差异有统计学意义（P0.05）。结论 在使用强心剂及利尿剂的基础上应用安体舒通和托拉塞米对慢性肺源性心脏病患者进行治疗，可以有效改善患者心功能症状，降低心功能分级，提高治疗效果。 　　[关键词]慢性肺源性心脏病；安体舒通；托拉塞米；临床效果 　　[中图分类号] R541.6 [文献标识码] A [文章编号] 1674-4721（2017）10（c）-0083-03 　　Study on the therapeutic effect of Spironolactone and Torasemide in patients with chronic pulmonary heart disease 　　ZENG Xing-du WU Guo-bin 　　Department of Respiratory Medicine，the First Affiliated Hospital of Gannan Medical College，Jiangxi Province，Ganzhou 341000，China 　　[Abstract]Objective To investigate the clinical effect of Spironolactone and Torasemide in patients with chronic pulmonary heart disease.Methods A total of 72 patients with chronic pulmonary heart disease who treated in our hospital from June 2015 to December 2016 were selected as objects and were randomly divided into control group and observation group according to the random number table method.There were 36 patients in each group.The control group was treated with Tonic and Diuretic and other conventional methods.The observation group was treated with Spironolactone and Torasemide on the basis of the control group.The clinical curative effect and cardiac function were compared between the two groups.Results The total effective rate in the observation group was 97.22% and 83.33% in the control group，the difference was statistically significant （P0.05）.After treatment，the patients of Ⅱ level in the control group was more than before treatment，the patients of Ⅳ level was less than before treatment，the difference was statistically significant （P 　　[Key words]Chronic pulmonary heart disease；Spironolactone；Torasemide；Clinical effect 　　慢性肺源性心脏病主要是由慢性阻塞性肺疾病导致的，在该疾病的